Clover Health Investments, Corp.
CLOV· Nasdaq
Released Feb 26, 2026, after the close
10-K filed Feb 27, 2026, 58 days after period end · 0001801170-26-000057
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $487.71M | $336.96M | $312.39M | — |
| Net Income | -$49.32M |
Clover Health Investments, Corp. · CIK 1801170 · Engraved from SEC EDGAR
| -$22.09M |
| -$70.47M |
| -$84.23M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.